Does abnormal glycogen structure contribute to increased susceptibility to seizures in epilepsy?

M DiNuzzo, S Mangia, B Maraviglia, F Giove - Metabolic brain disease, 2015 - Springer
Epilepsy is a family of brain disorders with a largely unknown etiology and high percentage
of pharmacoresistance. The clinical manifestations of epilepsy are seizures, which originate …

Seizure outcome after anterior temporal lobectomy and its predictors in patients with apparent temporal lobe epilepsy and normal MRI

PN Sylaja, K Radhakrishnan, C Kesavadas… - …, 2004 - Wiley Online Library
Purpose: Very little reliable information is available regarding the role of anterior temporal
lobectomy (ATL), optimal presurgical evaluation strategy, post‐ATL seizure outcome, and …

Epilepsy surgery: recommendations for India

PS Chandra, M Tripathi - Annals of Indian Academy of Neurology, 2010 - journals.lww.com
The following article recommends guidelines for epilepsy surgery for India. This article
reviews the indications, the various surgical options available and the outcome of surgery for …

Wasteosomes (corpora amylacea) as a hallmark of chronic glymphatic insufficiency

M Riba, J Del Valle, L Molina-Porcel… - Proceedings of the …, 2022 - National Acad Sciences
In different organs and tissues, the lymphatic system serves as a drainage system for
interstitial fluid and is useful for removing substances that would otherwise accumulate in the …

Clinico-pathological factors influencing surgical outcome in drug resistant epilepsy secondary to mesial temporal sclerosis

BVS Sastri, A Arivazhagan, S Sinha… - Journal of the …, 2014 - Elsevier
Background Mesial temporal sclerosis (MTS) is the most common cause of drug resistant
epilepsy amenable for surgical treatment and seizure control. Methods This study analyzed …

Expression of β‑amyloid precursor protein in refractory epilepsy

X Sima, J Xu, J Li, W Zhong… - Molecular medicine …, 2014 - spandidos-publications.com
Abstract β‑amyloid precursor protein (β‑APP), also known as Aβ peptide, has a key role in
the pathogenesis of Alzheimer's disease, and is also likely to be involved in the …

Corpora amylacea in mesial temporal lobe epilepsy: clinico-pathological correlations

A Radhakrishnan, K Radhakrishnan… - Epilepsy research, 2007 - Elsevier
PURPOSE: To investigate the electro-clinical significance of premature accumulation of
corpora amylacea (CoA) in the resected hippocampus of patients with medically refractory …

Outcome of adult patients with temporal lobe tumours and medically refractory focal epilepsy

R Bauer, J Dobesberger, C Unterhofer… - Acta …, 2007 - Springer
Background. Tumours are a well-recognized cause of medically intractable epilepsies.
Tumours represent the primary pathology in 10%–30% of patients undergoing surgical …

Medically refractory epilepsy associated with temporal lobe ganglioglioma: characteristics and postoperative outcome

A Radhakrishnan, M Abraham… - Clinical neurology and …, 2006 - Elsevier
OBJECTIVES: To define the postoperative seizure outcome and its predictors in patients
with ganglioglioma-related temporal lobe epilepsy (TLE). PATIENTS AND METHODS: We …

[PDF][PDF] Corpora amylacea in aging brain and age-related brain disorders

D Pirici, C Margaritescu - J. Aging Gerontol, 2014 - academia.edu
Corpora amylacea (CA) are glycoprotein-based hyaline-like bodies that accumulate in
normal aging brain, and to an even greater extent, in the brains of patients suffering from a …